Aerovate Therapeutics, Inc. (AVTE)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

5

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Aug-24 6:00 PM View:	01-Aug-24 Option Exercise $2.62K	Dake Benjamin T See Remarks		Aerovate Therapeutics, Inc. - AVTE	1004% 1.29K to 14.25K	0	0	--	--	Show Txns Hide Txns

14-Jun-24 6:00 PM View:	14-Jun-24 Planned Option Sale ($375.45K)	Eldridge George A See Remarks		Aerovate Therapeutics, Inc. - AVTE	156% 1.96K to 5.02K	0	0	--	--	Show Txns Hide Txns

14-Jun-24 6:00 PM View:	13-Jun-24 Planned Option Sale ($147.00K)	Gillies Hunter Chief Medical Officer		Aerovate Therapeutics, Inc. - AVTE	72% 3.25K to 5.6K	0	0	--	--	Show Txns Hide Txns

17-May-24 7:10 PM View:	16-May-24 Planned Option Sale ($215.76K)	Noyes Timothy P Chief Executive Officer Director		Aerovate Therapeutics, Inc. - AVTE	0% --	0	0	--	--	Show Txns Hide Txns

20-Jun-24 5:56 PM View:	17-Jun-24 Private Purchase $1.55M	Ra Capital Management, LLC Director 10% Owner		Aerovate Therapeutics, Inc. - AVTE	11% 8.26M to 9.19M	0	0	--	--	Show Txns Hide Txns

11-Apr-24 6:00 PM View:	09-Apr-24 Private Sale ($334.48K)	Grayzel David S. Director		Aerovate Therapeutics, Inc. - AVTE	(1%) 1.81M to 1.8M	0	0	--	--	Show Txns Hide Txns

07-Feb-24 6:00 PM View:	05-Feb-24 Planned Option Sale ($80.25K)	Niven Ralph Chief Scientific Officer		Aerovate Therapeutics, Inc. - AVTE	0% 1.61K	0	0	--	--	Show Txns Hide Txns

14-Jun-24 6:00 PM View:	14-Jun-24 Planned Option Sale ($265.00K)	Verwijs Marinus CHIEF TECHNICAL OFFICER		Aerovate Therapeutics, Inc. - AVTE	0% --	0	0	--	--	Show Txns Hide Txns